Jeena Sikho Lifecare Limited (NSE:JSLL)

Jeena Sikho Lifecare Financials Overview

Financials in millions INR. Fiscal year is April - March.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Revenue Revenue Growth	8,014	8,014	4,691	3,244	2,039	1,466
Revenue Growth	70.84%	70.84%	44.59%	59.10%	39.13%	7.91%
Gross Profit Gross Profit Growth	7,098	7,098	4,330	2,981	1,870	1,314
Operating Income Operating Income Growth	3,017	3,017	1,167	881.75	432.25	149.47
Net Income Net Income Growth	2,219	2,219	907.29	692.06	337.44	112.32
Earnings Per Share EPS Growth	17.81	17.81	7.29	5.57	2.74	1.23
EPS Growth	144.17%	144.17%	31.01%	103.35%	121.81%	10.54%

Revenue by Segment

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Ayurvedic Products/Medicines Ayurvedic Products/Medicines Growth	4,157	4,157	-	-	-	-
Ayurvedic Healthcare Services Ayurvedic Healthcare Services Growth	3,834	3,834	-	-	-	-
Others Others Growth	22.67	22.67	-	-	-	-
Trading of Ayurvedic Medicines and Providing Ayurvedic Therapies Trading of Ayurvedic Medicines and Providing Ayurvedic Therapies Growth	-	-	4,691	3,244	2,039	1,466
Total Total Growth	8,014	8,014	4,691	3,244	2,039	1,466

Cash & Debt

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Investments Cash & Investments Growth	2,039	2,039	289.1	655.07	369.37	25.9
Total Debt Total Debt Growth	1,273	1,273	107.33	5.4	8.08	74.35
Net Cash (Debt) Net Cash Growth	766.49	766.49	181.77	649.68	361.29	-48.45
Net Cash Growth	321.68%	321.68%	-72.02%	79.82%	-	-
Net Cash Per Share Net Cash Per Share Growth	6.15	6.15	1.46	5.23	2.93	-0.53

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Operating Cash Flow Operating Cash Flow Growth	2,538	2,538	686.27	366.89	171.69	163.54
Capital Expenditures CapEx Growth	-340.54	-340.54	-1,118	-155.38	-391.95	-220.31
Free Cash Flow Free Cash Flow Growth	2,197	2,197	-432	211.51	-220.26	-56.77
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Gross Margin	88.58%	88.58%	92.31%	91.90%	91.69%	89.63%
Operating Margin	37.65%	37.65%	24.88%	27.18%	21.20%	10.20%
Pretax Margin	37.11%	37.11%	26.02%	28.95%	21.84%	10.30%
Profit Margin	27.68%	27.68%	19.34%	21.33%	16.55%	7.66%
FCF Margin	27.41%	27.41%	-9.21%	6.52%	-10.80%	-3.87%

Dividends

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023
Period Ending	Aug 2, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023
Dividend Per Share Dividend Per Share Growth	4.500	4.500	1.100	0.836	0.222
Dividend Per Share Growth	31.58%	309.09%	31.58%	276.24%	-
Dividend Yield	0.77%	0.83%	0.25%	0.50%	0.69%

Valuation

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 2, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
PE Ratio	32.91	30.24	59.81	30.23	11.86	-
Forward PE	21.31	38.92	-	-	-	-
P/FCF Ratio	33.16	30.54	-	98.92	-	-
PS Ratio	9.09	8.37	11.57	6.45	1.96	-

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 31, 2026

Data Sources Report a data error